Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.6730
+0.0351 (5.50%)
At close: Sep 15, 2026, 4:00 PM EDT
0.6594
-0.0136 (-2.02%)
After-hours: Sep 15, 2026, 7:36 PM EDT
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $163.84 million as of September 15, 2026. Its market cap has increased by 254.66% in one year.
Market Cap
163.84M
Enterprise Value
171.03M
1-Year Change
254.66%
Ranking
Category
Stock Price
$0.67
ChartMarket Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has increased from $97.37M to $163.84M, an increase of 68.27%. That is a compound annual growth rate of 5.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 163.84M | 61.74% |
| Dec 31, 2025 | 101.30M | 115.21% |
| Dec 31, 2024 | 47.07M | -54.10% |
| Dec 29, 2023 | 102.54M | -63.01% |
| Dec 30, 2022 | 277.20M | -9.11% |
| Dec 31, 2021 | 304.99M | 84.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Canton Strategic Holdings | 167.33M |
| Spruce Biosciences | 163.39M |
| Codexis | 162.07M |
| Corbus Pharmaceuticals Holdings | 156.28M |
| Humacyte | 155.84M |
| Tenaya Therapeutics | 155.37M |
| Jyong Biotech | 154.41M |
| Immunic | 153.23M |